Cargando…
Fumaric Acid and its Esters: An Emerging Treatment for Multiple Sclerosis
Fumaric acid is an intermediate product of the citric acid cycle that is a source of intracellular energy in the form of adenosine triphosphate (ATP). It is generated by oxidation of adenylsuccinate by the enzyme succinate dehydrogenase and is then converted to maleate by the enzyme fumarase. At pre...
Autores principales: | Moharregh-Khiabani, D, Linker, R.A, Gold, R, Stangel, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd.
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724664/ https://www.ncbi.nlm.nih.gov/pubmed/19721818 http://dx.doi.org/10.2174/157015909787602788 |
Ejemplares similares
-
Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters
por: Lee, De-Hyung, et al.
Publicado: (2012) -
Effects of Fumaric Acids on Cuprizone Induced Central Nervous System De- and Remyelination in the Mouse
por: Moharregh-Khiabani, Darius, et al.
Publicado: (2010) -
The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis
por: Hammer, Anna, et al.
Publicado: (2018) -
Efficacy of Fumaric Acid Esters in the R6/2 and YAC128 Models of Huntington's Disease
por: Ellrichmann, Gisa, et al.
Publicado: (2011) -
Fumaric acid esters in dermatology
por: Wollina, Uwe
Publicado: (2011)